These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21136735)

  • 1. Proteomics of human cerebrospinal fluid - the good, the bad, and the ugly.
    Zhang J
    Proteomics Clin Appl; 2007 Aug; 1(8):805-19. PubMed ID: 21136735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
    Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
    J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CSF biomarkers: proteomics investigations and clinical applications in neurodegenerative disorders].
    Gabelle A; Roche S; Lehmann S
    Rev Neurol (Paris); 2009 Mar; 165(3):213-22. PubMed ID: 18808768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of glycoproteins in human cerebrospinal fluid.
    Hwang HJ; Quinn T; Zhang J
    Methods Mol Biol; 2009; 566():263-76. PubMed ID: 20058177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry.
    Pan S; Zhu D; Quinn JF; Peskind ER; Montine TJ; Lin B; Goodlett DR; Taylor G; Eng J; Zhang J
    Proteomics; 2007 Feb; 7(3):469-73. PubMed ID: 17211832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics.
    Kroksveen AC; Opsahl JA; Aye TT; Ulvik RJ; Berven FS
    J Proteomics; 2011 Apr; 74(4):371-88. PubMed ID: 21111852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF).
    Maurer MH
    Mass Spectrom Rev; 2010; 29(1):17-28. PubMed ID: 19116946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical proteomics in neurodegenerative diseases.
    Zhou JY; Hanfelt J; Peng J
    Proteomics Clin Appl; 2007 Nov; 1(11):1342-50. PubMed ID: 21136634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects.
    Cedazo-Minguez A; Winblad B
    Exp Gerontol; 2010 Jan; 45(1):5-14. PubMed ID: 19796673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive proteome map of bovine cerebrospinal fluid.
    Brenn A; Karger A; Skiba M; Ziegler U; Groschup MH
    Proteomics; 2009 Nov; 9(22):5199-205. PubMed ID: 19921684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers.
    Roche S; Gabelle A; Lehmann S
    Proteomics Clin Appl; 2008 Mar; 2(3):428-36. PubMed ID: 21136844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent cerebrospinal fluid biomarker studies of Alzheimer's disease.
    Choi YS; Choe LH; Lee KH
    Expert Rev Proteomics; 2010 Dec; 7(6):919-29. PubMed ID: 21142892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteome studies of CSF in AD patients.
    Davidsson P; Sjögren M
    Mech Ageing Dev; 2006 Feb; 127(2):133-7. PubMed ID: 16293296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease cerebrospinal fluid biomarker discovery: a proteomics approach.
    D'Ascenzo M; Relkin NR; Lee KH
    Curr Opin Mol Ther; 2005 Dec; 7(6):557-64. PubMed ID: 16372405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined analysis of the glia secretome and the CSF proteome: neuroinflammation and novel biomarkers.
    Suk K
    Expert Rev Proteomics; 2010 Apr; 7(2):263-74. PubMed ID: 20377392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics-driven progress in neurodegeneration research.
    Fountoulakis M; Kossida S
    Electrophoresis; 2006 Apr; 27(8):1556-73. PubMed ID: 16555340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker discovery in neurodegenerative diseases: a proteomic approach.
    Shi M; Caudle WM; Zhang J
    Neurobiol Dis; 2009 Aug; 35(2):157-64. PubMed ID: 18938247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteome analysis in the clinical chemistry laboratory: myth or reality?
    Righetti PG; Castagna A; Antonucci F; Piubelli C; Cecconi D; Campostrini N; Rustichelli C; Antonioli P; Zanusso G; Monaco S; Lomas L; Boschetti E
    Clin Chim Acta; 2005 Jul; 357(2):123-39. PubMed ID: 15970281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.